Improving treatment engagement for early psychosis through shared decision making about antipsychotic medications
Examining the effectiveness of a shared decision making intervention for antipsychotic medications to improve engagement in treatment for people experiencing early psychosis
['FUNDING_OTHER'] · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · NIH-10670896
This study is all about helping people with early psychosis and their doctors have better conversations about antipsychotic medications, so they can make informed choices together and stick to their treatment plans more easily.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC (nih funded) |
| Locations | 1 site (NEW YORK, UNITED STATES) |
| Trial ID | NIH-10670896 on ClinicalTrials.gov |
What this research studies
This research focuses on enhancing the way patients and clinicians communicate about antipsychotic medications, particularly for individuals experiencing early psychosis. By implementing a shared decision-making (SDM) approach, the project aims to foster open discussions that can lead to better treatment engagement and adherence. The study will develop and test an evidence-based intervention called the Antipsychotic Medication Decision Aid (APM-DA) to help patients make informed choices about their medication. This approach addresses the current gap in psychiatric care where SDM is often overlooked, especially for those at high risk of relapse.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals experiencing their first episode of psychosis who are considering or currently prescribed antipsychotic medications.
Not a fit: Patients who are not experiencing early psychosis or those who are not prescribed antipsychotic medications may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment adherence and outcomes for patients with early psychosis.
How similar studies have performed: Previous research has shown that shared decision-making approaches can improve patient engagement in various medical fields, suggesting potential success for this novel application in psychiatric care.
Where this research is happening
NEW YORK, UNITED STATES
- NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC — NEW YORK, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: DIXON, LISA B. — NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC
- Study coordinator: DIXON, LISA B.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Chronic Disease